Young adults experiencing warning signs of colon cancer face a frustrating insurance barrier: while the Affordable Care Act (ACA) covers preventive colonoscopies for people over 45, it doesn't require the same coverage for diagnostic colonoscopies in younger patients with symptoms. This gap is creating a dangerous delay in diagnosis at a time when colon cancer rates among people in their 20s and 30s are climbing faster than any other age group. Why Is Colon Cancer Rising So Dramatically in Young Adults? The numbers are striking. Nationally, tens of thousands of people under age 50 are now diagnosed with colorectal cancer each year, nearly double the proportion seen two decades ago. Research from the International Agency for Research on Cancer shows that while the risk of colon cancer continues to rise with age, the number of young people getting diagnosed is going up, while rates for people over 60 are declining. What makes this trend particularly troubling is that many younger patients don't fit traditional risk profiles. "They are frequently active, maintain a healthy weight, and lack a family history of colorectal cancer," explained a City of Hope oncologist. City of Hope Oncologist, City of Hope The causes remain mysterious. Genetics, diet, microbiome changes, antibiotic exposure, ultra-processed foods, and environmental factors have all been proposed as contributors, but no single factor explains the magnitude or pace of the increase. How Does the Insurance Coverage Gap Actually Work? The distinction between preventive and diagnostic colonoscopies is the crux of the problem. Under the ACA, insurance companies must cover colonoscopies for people over 45 because the U.S. Preventive Services Task Force recommends them as a screening tool. But for people under 45 with symptoms like rectal bleeding, a colonoscopy is classified as a diagnostic test, not a screening test, and coverage varies widely depending on the insurance plan. "For people under 45, if you have symptoms like rectal bleeding, a colonoscopy would be considered a diagnostic test, and so it's not going to be covered in the same way as a screening test would be," explained Caitlin Murphy, a cancer epidemiologist and professor at the University of Chicago. Caitlin Murphy, Cancer Epidemiologist and Professor, University of Chicago The real-world consequences are severe. One 35-year-old software engineer named Dominick living in Florida experienced bowel movement changes, stomach pain, and weight loss. His doctor recommended a colonoscopy, and his insurance initially approved it. Then, three hours before the procedure was scheduled, he received a call saying it wouldn't be covered because it was classified as diagnostic. The out-of-pocket cost was roughly $2,000, which he paid with a credit card. The procedure revealed a precancerous polyp that he had removed, but he acknowledged it was terrifying to think about what could have happened if he hadn't been able to find a way to pay. What Barriers Do Young Patients Face Beyond Cost? The insurance approval process itself can be a major obstacle. Doctors often attribute symptoms in younger patients to benign conditions like hemorrhoids or irritable bowel syndrome, leading to what experts call "referral loops." "I hear at least once a week, someone who has had symptoms for years, and they get stuck in these referral loops. They go from doctor to doctor and don't get evaluated. That's a huge problem that seems fixable to me," said Caitlin Murphy. Caitlin Murphy, Cancer Epidemiologist and Professor, University of Chicago This diagnostic delay is particularly dangerous because younger patients often arrive with advanced disease. Approximately 40 percent of patients under 50 present with rectal cancer, a substantially higher rate than in older populations, and advanced disease means treatment becomes more complex with greater long-term consequences. Steps to Advocate for Colon Cancer Screening if You're Under 45 - Document Your Symptoms: Keep a detailed record of any rectal bleeding, changes in bowel habits, abdominal discomfort, or unexplained weight loss. Bring this documentation to your doctor's appointment to strengthen your case for a diagnostic colonoscopy. - Ask About Stool Tests First: If your insurance is denying a colonoscopy, ask your doctor about a stool test such as Cologuard. These tests may help speed up the approval process for a diagnostic colonoscopy by providing preliminary evidence of concern. - Appeal Insurance Denials: If your insurance company denies coverage for a diagnostic colonoscopy, file an appeal. Request that your doctor provide clinical justification for why the test is medically necessary given your specific symptoms. - Explore Financial Assistance Programs: Ask your gastroenterology clinic about payment plans, financial assistance programs, or clinical trials that might cover the cost of a colonoscopy if insurance won't. What Would It Take to Fix This Problem? Experts are divided on whether lowering the recommended screening age below 45 is the right solution. When the American Cancer Society pushed for the age reduction to 45 in 2018, there was substantial pushback. "People were saying the risk was too low. We were going to take screening away from older adults who have a higher burden, and we were going to exacerbate disparities, because young people were going to be taking screening away from people of color," noted Rebecca Siegel, an epidemiologist at the American Cancer Society. Rebecca Siegel, Epidemiologist, American Cancer Society There are also practical constraints. There are only so many gastroenterologists available, and a colonoscopy comes with its own risks. However, since the screening age was lowered to 45, data has shown that earlier screening likely helped more patients catch their cancer earlier. Rather than simply lowering the screening age further, experts suggest a two-pronged approach. First, insurance policies should be updated to cover diagnostic colonoscopies for symptomatic patients under 45 without the same barriers. Second, researchers need to understand what's actually causing the surge in early-onset colon cancer. "There are probably thousands of possibilities as to what's causing the increase in colon cancer, and researchers should start using methods that allow us to at least get to a list of top 10 suspects by considering thousands of possibilities at once," said Caitlin Murphy. Caitlin Murphy, Cancer Epidemiologist and Professor, University of Chicago One promising research direction is studying the "exposome," which is the entirety of exposures in a person's lifetime. Mass spectrometry technology now allows researchers to ascertain many lifetime exposures from small amounts of blood or plasma. Understanding what environmental, dietary, or lifestyle factors are driving early-onset colon cancer could eventually lead to prevention strategies that reduce the disease burden altogether. For now, young adults experiencing symptoms should not assume they're too young to have colon cancer. If you're experiencing rectal bleeding, persistent changes in bowel habits, or unexplained abdominal pain, push for evaluation. The insurance system may not make it easy, but early detection can be lifesaving.
